No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 2.6300
- -0.0400-1.50%
Close Dec 20 16:00 ET
- 2.8400
- +0.2100+7.98%
Post 18:18 ET
3.33MMarket Cap-0.18P/E (TTM)
2.8100High2.5775Low23.97KVolume2.6700Open2.6700Pre Close64.47KTurnover2.64%Turnover RatioLossP/E (Static)1.27MShares9.400052wk High0.19P/B2.39MFloat Cap2.370052wk Low--Dividend TTM908.92KShs Float170.0000Historical High--Div YieldTTM8.71%Amplitude2.3700Historical Low2.6890Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Pasithea Therapeutics: Entered Into Sales Agreement Relating to Sale of Shares of Common Stock of up to $2.1 Mln From Time to Time
Express News | Pasithea Therapeutics Corp - Src Recommends Escalation to 15Mg Dose Level
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation From Its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
Express News | Pasithea Therapeutics Announces Positive Safety Review Committee (Src) Recommendation From Its Ongoing Phase 1 Clinical Trial of Pas-004 in Advanced Cancer
10-Q: Q3 2024 Earnings Report
Pasithea Therapeutics Files to Sell 3.74M Shares of Common Stock for Holders
Heat List
US
Overall
Symbol
Price
% Chg
No Data